High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Michael P. Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet · 2001 · 6.1K citations

Medicine, Internal Medicine, Pharmacotherapy +17

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

Stefan Zeuzem, S.V. Feinman, J. Rasenack et al. · New England Journal of Medicine · 2000 · 1.2K citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C

Karen L. Lindsay, Christian Trépo, Tobias Heintges et al. · Hepatology · 2001 · 665 citations

Pharmacy, Pharmacology, Pharmacotherapy +15

Peginterferon alfa‐2b plus ribavirin treatment in children and adolescents with chronic hepatitis C†

Stéfan Wirth, Heidrun Pieper-Boustani, Thomas Lang et al. · Hepatology · 2005 · 202 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Interferon Alfa-2b in Combination With Ribavirin for the Treatment of Chronic Hepatitis C in Children: Efficacy, Safety, and Pharmacokinetics *

Regino P. González‐Peralta, Déirdre Kelly, Barbara Haber et al. · Hepatology · 2005 · 158 citations · Full text

Pharmacy, Infectious Diseases, Pharmacokinetics +17